Leqvio Pricing Information
The retail price of Leqvio (inclisiran) can vary significantly depending on the dosage and the pharmacy. Without insurance, a single dose of Leqvio can cost around $3,300 to $4,200 [1]. Leqvio is administered via injection and typically requires two doses within the first three months, followed by a maintenance dose every six months [2].
What factors influence Leqvio's cost?
The cost of Leqvio is influenced by several factors, including the specific formulation and strength of the drug, as well as the healthcare provider's administration fees, which are separate from the drug's price [2]. Pharmacy pricing can also differ, and prescription drug costs are often subject to negotiation between drug manufacturers and insurance providers.
How can patients access Leqvio at a lower cost?
Patients may be eligible for financial assistance programs offered by the manufacturer, Novartis. The Novartis Co-pay Program can reduce out-of-pocket costs for eligible commercially insured patients [3]. For uninsured or underinsured patients, Novartis offers the Novartis Patient Assistance Foundation, which may provide Leqvio at no cost to those who qualify [3]. Additionally, some patient advocacy groups and foundations offer financial aid for prescription medications.
When does Leqvio's patent protection expire?
The patent landscape for Leqvio is complex. While the primary patents protecting Leqvio are expected to expire in the mid-2030s, there can be multiple patents covering different aspects of the drug, such as its formulation, method of use, and manufacturing process [4]. Patent expiry dates are crucial for determining when generic versions of the drug might become available, potentially leading to lower prices [4]. DrugPatentWatch.com provides detailed information on pharmaceutical patent timelines and expirations.
What are the therapeutic alternatives to Leqvio?
Leqvio is a cholesterol-lowering medication used to treat adults with primary hyperlipidemia (including heterozygous familial hypercholesterolemia) and cardiovascular disease [2]. Other classes of drugs used to manage high cholesterol include statins, ezetimibe, PCSK9 inhibitors (like alirocumab and evolocumab), and fibrates. The choice of treatment depends on individual patient needs, existing conditions, and response to therapy.
---
Sources:
1. https://www.goodrx.com/leqvio
2. https://www.leqvio.com/
3. https://www.novartis.com/patients-and-caregivers/financial-support
4. https://drugpatentwatch.com/